News >

Advances Continue at Rapid Pace in CLL Paradigm

Brittany Cote
Published: Tuesday, Jan 21, 2020

Bita Fakhri, MD

Bita Fakhri, MD

The chronic lymphocytic leukemia (CLL) paradigm has evolved significantly with the addition of combination strategies, more selective BTK inhibitors, and fixed-duration approaches. Therefore, the next question being asked in the field is how to choose among the various options for patients, explained Bita Fakhri, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication